C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2325806
The present invention relates to the diagnosis of the distinction between acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) and prognosis of AML. Disclosed is a means to diagnose the distinction between ALL and AML employing measurement of the abundance of the nucleic acid or protein products of small combinations (two, three or more) of particular human genes. The invention further describes the use of the measurement of the abundance of the nucleic acid or protein product of two human genes for prognostic indication in AML. The invention also relates to therapies targeted at these indicator genes, and the screening of drugs for cancer that target these indicator genes or their protein products.
Anderson Gary E.
Dunne Roderick J.
Lepage Marc A.
Misener Stephen R.
Steeg Evan W.
Molecular Mining Corporation
Wilkes Robert H.
LandOfFree
Methods for the diagnosis and prognosis of acute leukemias does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the diagnosis and prognosis of acute leukemias, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the diagnosis and prognosis of acute leukemias will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1912204